Sign Up to like & get
recommendations!
0
Published in 2018 at "Melanoma Research"
DOI: 10.1097/cmr.0000000000000407
Abstract: Although immune therapies with checkpoint inhibitors have gained increasing attention in advanced and metastatic melanoma, interferon-&agr; remains a standard therapy for nonmetastatic malignant melanoma with risk factors. Interferons can successfully prevent relapse; however, the response…
read more here.
Keywords:
epithelial tumor;
tumor cells;
malignant melanoma;
circulating epithelial ... See more keywords